Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Amy K Sheaffer"'
Autor:
Amy K Sheaffer, Min S Lee, Huilin Qi, Susan Chaniewski, Xiaofan Zheng, Glen A Farr, Kim Esposito, David Harden, Ming Lei, Liang Schweizer, Jacques Friborg, Michele Agler, Fiona McPhee, Robert Gentles, Brett R Beno, Lou Chupak, Stephen Mason
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0155909 (2016)
A phenotypic high-throughput cell culture screen was performed to identify compounds that prevented proliferation of the human Papilloma virus type 16 (HPV-16) transformed cell line Ca Ski. A series of quinoxaline compounds exemplified by Compound 1
Externí odkaz:
https://doaj.org/article/0b210787c3874e4696b86d353003b927
Autor:
Alan Xiangdong Wang, Andrew C. Good, Fei Yu, Peter Hrnciar, Herbert E. Klei, Manjula Paruchuri, Fiona McPhee, Dennis Hernandez, Paul Falk, Jeffrey Tredup, Amy K. Sheaffer, Qi Gao, Barbara Zheng, Kevin Kish, Kathy Mosure, Stanley D'andrea, Ramkumar Rajamani, Alicia Ng, Jay O. Knipe, Yan Chen, Li-Qiang Sun, Jacques Friborg, Paul Michael Scola, Arvind Mathur, Nicholas A. Meanwell, Richard Rampulla
The design and synthesis of potent, tripeptidic acylsulfonamide inhibitors of HCV NS3 protease that contain a difluoromethyl cyclopropyl amino acid at P1 are described. A cocrystal structure of 18 with a NS3/4A protease complex suggests the presence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deb2005e8a0764575ac7a4f49607aedd
https://europepmc.org/articles/PMC5807875/
https://europepmc.org/articles/PMC5807875/
Autor:
Danshi Li, Herbert E. Klei, Sing-Yuen Sit, Piyasena Hewawasam, Ny Sin, Brian Lee Venables, Paul Levesque, Qi Gao, Bilder Donna M, Dennis M. Grasela, Dennis Hernandez, Anthony J. Cocuzza, Amy K. Sheaffer, Richard J. Colonno, Jeffrey Tredup, Kathy Mosure, Stanley D'andrea, Jialong Zhu, Lucy Sun, Fei Yu, Paul Falk, Alan Xiangdong Wang, Steven Levine, Fiona McPhee, Andrew C. Good, Huabin Sun, Jay O. Knipe, Barbara Zheng, Richard Schartman, Nicholas A. Meanwell, Jie Chen, Maria Donoso, James Loy, Guangzhi Zhai, Ramkumar Rajamani, Li-Qiang Sun, Stephen P. Adams, Luciano Mueller, Tatyana Zvyaga, Yong Tu, Hong Shi, Paul Michael Scola, Chaoqun Chen, William Warner, Yan Chen, Yong-Hae Han, Diana Barry, Jacques Friborg, Kevin Kish, Michael Sinz
Publikováno v:
Journal of Medicinal Chemistry. 57:1730-1752
The discovery of asunaprevir (BMS-650032, 24) is described. This tripeptidic acylsulfonamide inhibitor of the NS3/4A enzyme is currently in phase III clinical trials for the treatment of hepatitis C virus infection. The discovery of 24 was enabled by
Autor:
Alan Xiangdong Wang, Barbara Zheng, Min S. Lee, Dennis Hernandez, Andrew C. Good, Stanley D'andrea, Amy K. Sheaffer, Fiona McPhee, Christoph Gesenberg, Sing-Yuen Sit, Ny Sin, Paul Falk, Danshi Li, Piyasena Hewawasam, Yan Chen, Yong-Hae Han, Paul Levesque, Brian Lee Venables, Nicholas A. Meanwell, Michael Sinz, Wenying Li, Qi Gao, Li-Qiang Sun, Jay O. Knipe, Chaoqun Chen, Caly Chien, Diana Barry, Guangzhi Zhai, Anthony J. Cocuzza, Tatyana Zvyaga, Stephen P. Adams, Jialong Zhu, Fei Yu, Dennis M. Grasela, Richard J. Colonno, Yong Tu, Ramkumar Rajamani, Herbert E. Klei, Jianqing Li, Min Ding, Jan Willem Thuring, Jie Chen, Susan Jenkins, Keith D. Combrink, Jeffrey Allen Campbell, Kenneth S. Santone, Paul Michael Scola, Eric Hughes, Bilder Donna M
Publikováno v:
Journal of Medicinal Chemistry. 57:1708-1729
The discovery of BMS-605339 (35), a tripeptidic inhibitor of the NS3/4A enzyme, is described. This compound incorporates a cyclopropylacylsulfonamide moiety that was designed to improve the potency of carboxylic acid prototypes through the introducti
Autor:
Amy K. Sheaffer, Steven Levine, Voss Stacey A, Fiona McPhee, Julie A. Lemm, Chaoqun Chen, Susan Chaniewski, Jacques Friborg
Publikováno v:
Antimicrobial Agents and Chemotherapy. 57:1312-1322
The clinical efficacy of a pegylated form of human lambda 1 interferon (IFN-λ1; also referred to herein as lambda) has been demonstrated in patients chronically infected with hepatitis C virus (HCV) representing genotypes 1 through 4. In these proof
Autor:
Huabin Sun, Hua Fang, Richard Rampulla, Alan Xiangdong Wang, Bilder Donna M, Bang-Chi Chen, Zhao Qian, Chaoqun Chen, Brian Lee Venables, Fiona McPhee, Jie Chen, Maria Donoso, Barbara Zheng, Paul Falk, Ying-Kai Wang, Yan Chen, Nicholas A. Meanwell, Yong-Hae Han, Qi Gao, Richard Schartman, Luciano Mueller, Steven Levine, Herbert E. Klei, Jacques Friborg, Stephen P. Adams, Ramkumar Rajamani, Anthony J. Cocuzza, Theerthagiri Palani, Dennis M. Grasela, Dennis Hernandez, Fei Yu, Sivakumar Ganesan, James Loy, Tatyana Zvyaga, Paul Levesque, Li-Qiang Sun, Amy K. Sheaffer, Eric Mull, Arvind Mathur, Kathy Mosure, Jeffrey Tredup, Stanley D'andrea, Pirama Nayagam Arunachalam, Jialong Zhu, Mark I. Cockett, Hong Shi, Sing-Yuen Sit, Ny Sin, Paul Michael Scola, Jay O. Knipe, Alicia Ng, William Warner, Kevin Kish, Lucy Sun, Michael Sinz, Danshi Li
Publikováno v:
Journal of medicinal chemistry. 59(17)
The discovery of a back-up to the hepatitis C virus NS3 protease inhibitor asunaprevir (2) is described. The objective of this work was the identification of a drug with antiviral properties and toxicology parameters similar to 2, but with a preclini
Autor:
Min S. Lee, Steven Levine, Richard J. Colonno, Kathy Mosure, Paul Michael Scola, Nicholas A. Meanwell, Chaoqun Chen, Michael Sinz, Li-Qiang Sun, Susan Chaniewski, Fiona McPhee, Paul Falk, Jacques Friborg, Fei Yu, Diana Barry, Dennis Hernandez, Amy K. Sheaffer, Guangzhi Zhai, Jay O. Knipe
Publikováno v:
Antimicrobial Agents and Chemotherapy. 56:5387-5396
Asunaprevir (ASV; BMS-650032) is a hepatitis C virus (HCV) NS3 protease inhibitor that has demonstrated efficacy in patients chronically infected with HCV genotype 1 when combined with alfa interferon and/or the NS5A replication complex inhibitor dac
Autor:
Dennis Hernandez, Amy K. Sheaffer, Fei Yu, Jacques Friborg, Fiona McPhee, Chaoqun Chen, Claudio Pasquinelli, Susan Chaniewski, Paul Falk, Min S. Lee, Steven Levine
Publikováno v:
Antimicrobial Agents and Chemotherapy. 56:3670-3681
Asunaprevir (BMS-650032) is a potent hepatitis C virus (HCV) NS3 protease inhibitor demonstrating efficacy in alfa interferon-sparing, direct-acting antiviral dual-combination regimens (together with the NS5A replication complex inhibitor daclatasvir
Autor:
Juan Carlos Lopez-Talavera, Ronald Goldwater, Thomas Marbury, Michael Charlton, Dennis Hernandez, Walter K. Kraft, Eric Lawitz, Amy K. Sheaffer, Claudio Pasquinelli, David Wright, Maribel Rodriguez-Torres, Shu-Pang Huang, Michael DeMicco, Timothy Eley, Dennis M. Grasela, Pamela Sheridan, Criselda Villegas, Paul Michael Scola, Katrina Sandy, Anna Persson, Fiona McPhee
Publikováno v:
Antimicrobial Agents and Chemotherapy. 56:1838-1844
Hepatitis C virus (HCV) protease inhibitors combined with pegylated alfa interferon-ribavirin have demonstrated improved efficacy compared with pegylated alfa interferon-ribavirin alone for the treatment of chronic hepatitis C. Asunaprevir (BMS-65003
Autor:
Amy K. Sheaffer, Glen A. Farr, Min S. Lee, Lou Chupak, Liang Schweizer, Ming Lei, Stephen W. Mason, Kim Esposito, Susan Chaniewski, David G. Harden, Xiaofan Zheng, Brett R. Beno, Huilin Qi, Fiona McPhee, Michele Agler, Robert G. Gentles, Jacques Friborg
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 6, p e0155909 (2016)
PLoS ONE, Vol 11, Iss 6, p e0155909 (2016)
A phenotypic high-throughput cell culture screen was performed to identify compounds that prevented proliferation of the human Papilloma virus type 16 (HPV-16) transformed cell line Ca Ski. A series of quinoxaline compounds exemplified by Compound 1